Hematology and Oncology
Home Hematology and Oncology
Extended INR Test Intervals Safe for Warfarin-Treated Patients
Similar number of out-of-range next INR values for patients with, without extended testing interval
Lung Cancer Incidence Higher for Young Women Than Young Men
Crossover in sex-specific rates among U.S. non-Hispanic whites born since 1965
Addressing Parents’ HPV Vaccine Hesitancy Ups Vaccination Rates
More adolescents receive HPV vaccination same day with physician engagement versus acquiescence
From 2008 to 2014, Prostate Cancer Testing, Treatment Down
Sharpest decrease seen in privately insured men after 2011
CDC: No Change in Level of Uninsured in U.S. in 2017
Five percent of children uninsured in 2017, 41.3 and 55.0 percent had public and private coverage
Surveillance Frequency Doesn’t Cut Mortality in Colorectal Cancer
And, intensity of imaging surveillance not linked to time to detection of colorectal cancer recurrence
Rivaroxaban Linked to Low VTE Recurrence in Active Cancer
Lower rate of VTE recurrence, but higher clinically relevant non-major bleeding versus dalteparin
FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures
Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure
Breath Test Shows Promise for Diagnosis of Esophagogastric CA
Good diagnostic accuracy with area under the curve of 0.85, sensitivity and specificity of 80, 81 percent
V600E BRAF Mutation Tied to Worse Survival in CRC Liver Mets
Worse overall, disease-free survival with V600E BRAF versus KRAS mutation in colorectal liver metastases
